ARCHIVES

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 40 | October 20, 1995

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

November 26, 1999

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

February 23, 1996

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

March 22, 2002

New NCI advisory Boards Appointed, Begin Review Of NCI Programs

March 29, 1996

HHS lawyer tells of pressure to allow former NCI Director Richard Klausner to receive $40,000 prize.

May 21, 2004